Peak antifactor xa activity produced by dalteparin treatment in patients with renal impairment compared with controls. [electronic resource]
Producer: 20050927Description: 817-22 p. digitalISSN:- 0277-0008
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.